📋 Tender Overview
Project Number: 48629
Company Name: Luminova Pharma Alliance, Inc.
Date ESRS Disclosed: Jul 15, 2024
Country: Guatemala
Region: Latin America and the Caribbean
Environmental Category: B
Status: Pending Approval
Department: Regional Industry MAS LAC & EUR
Project Description
Luminova Pharma Group ( Luminova , or the Group ) is a private, family-owned pharmaceutical group founded 60 years ago and is based in Guatemala engaging in the development, manufacture, and commercialization of generics (mainly branded generics). Luminova owns two manufacturing facilities in Guatemala, with capacity for solids, semisolids, liquids, and injectables production. The company also distributes and commercializes generics in twelve countries in Central America and South American region through its own distribution function and third-party operators. The proposed investment consists of up to USD 50 million long-term financing which includes the acquisition of pharmaceutical companies located in Spain, maintenance capex, and working capital requirements. The project does not involve any new greenfield development of infrastructures.
Financing Sources:
2) World Bank (WB)
1818 H Street, NW Washington, DC 20433 USA
Tel : (202) 473-1000
https://www.worldbank.org/
